Corbus Pharmaceuticals Holdings, Inc. · MUN:3371

Corbus Pharmaceuticals Holdings, Inc. insider trades

Corbus Pharmaceuticals Holdings, Inc.'s insiders made 3 buys and 7 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

TradeTradeSharesPriceValueDate
Cormorant Asset Management, LP
Other: Former 10% Owner
Sale425,000USD 4.10US$1.74MOct 29, 2026
Ben Yong
Director
Sale2,000USD 7.84US$15,680Sep 14, 2026
Saxena Nishant C
Officer: Chief Business Officer
Buy2,600USD 9.63US$25,038Aug 11, 2026
Moran Sean F.
Officer: Chief Financial Officer
Sale12,000USD 10.08US$121KAug 7, 2026
Cohen Yuval
Director, Officer: Chief Executive Officer
Sale17,000USD 10.08US$171KAug 7, 2026
Altmeyer Anne
Director
Sale2,412USD 7.91US$19,079Jun 10, 2026
Jenkins John Kenneth
Director
Sale4,800USD 7.91US$37,968Jun 10, 2026
Kung Winston
Director
Sale2,026USD 7.91US$16,026Jun 10, 2026
Saxena Nishant C
Officer: Chief Business Officer
Buy9,000USD 7.58US$68,220Jun 3, 2026
Saxena Nishant C
Officer: Chief Business Officer
Buy4,500USD 7.33US$32,985Jun 2, 2026

Corbus Pharmaceuticals Holdings, Inc. shareholders